Avid Radiopharmaceuticals: Clinical Trials

67 trials sponsored by Avid Radiopharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 6 terminated, 3 active not recruiting, 3 recruiting. 19 Phase 2, 18 Phase 1, 14 Phase 3, 6 Early Phase 1, 6 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 219Completed 16, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 118Completed 15, Terminated 2, Withdrawn 1
Phase 314Completed 12, Active not recruiting 1, Recruiting 1
Early Phase 16Completed 3, Terminated 2, Unknown 1
Not applicable6Completed 4, Active not recruiting 1, Withdrawn 1
Phase 46Completed 4, Active not recruiting 1, Terminated 1

Follow Avid Radiopharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F-LY3950321-01 Biodistribution and Safety Study
18F-LY3950321, PET Scan - Diagnostic Agent Adverse Reaction, Radiation Exposure
Early Phase 1CompletedAvid Radiopharmaceuticals62023-02-282023-04-28
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
18F-LY3546117 Injection, PET Scan - Neoplasms, Neoplasms Malignant
Early Phase 1UnknownAvid Radiopharmaceuticals302022-04-122022-04-25
University of Pittsburgh Brain Health Initiative
Cognitive/Neuropsychological Testing, Vestibular/Ocular-Motor Testing, Sleep Evaluation - Traumatic Brain Injury
RecruitingDavid Okonkwo, MD, PhD3002019-11-182026-06-22
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 3CompletedAvid Radiopharmaceuticals2052019-03-282020-08-28
A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
flortaucipir F 18 - Alzheimer Disease
Phase 3CompletedAvid Radiopharmaceuticals2422019-03-262020-09-09
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
DaTscan, F18-AV-45, FDG-PET - Alzheimer's Disease, Lewy Body Dementia
RecruitingDouglas Scharre762018-08-302026-10-15
Tau Screening Study in Subjects With Early Symptomatic AD
Flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 2CompletedAvid Radiopharmaceuticals1612018-03-082020-08-24
Tau Screening Study in Patients With Early Symptomatic AD
Flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 2CompletedAvid Radiopharmaceuticals1552017-11-212020-08-24
Flortaucipir PET Imaging in Subjects With FTD
Flortaucipir F18, Brain PET scan - Frontotemporal Dementia
Phase 1CompletedAvid Radiopharmaceuticals162017-04-112020-09-25
Flortaucipir 18F PET Imaging in BIOCARD Study
Flortaucipir F18, Brain PET scan - Cognitive Decline
Phase 1TerminatedAvid Radiopharmaceuticals232017-03-232020-09-25
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
F-18 florbetapir - Cardiac Amyloidosis
Phase 4TerminatedThe Cleveland Clinic122017-01-012021-07-27
18F-AV-1451 High Resolution Autopsy Study
Flortaucipir F18 - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals32016-11-262025-06-10
Imaging Tau Deposition in the Brain of Elderly Subjects
18F-AV-1451 (Tau-PET tracer) - Mild Cognitive Impairment, Healthy
Not applicableActive not recruitingUniversity of Zurich1412016-11-012023-11-09
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
florbetapir F 18 PET scan - Alzheimer Disease, Cognition Disorders
CompletedAvid Radiopharmaceuticals3172016-10-012018-10-24
PET Tau - Neurodegenerative Disease Imaging
18F-AV-1451 - Neurodegenerative Disease
Phase 2 / Phase 3RecruitingUniversity of Pennsylvania3002016-08-232026-10-16
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
Flortaucipir F18, PET Scan - Alzheimer's Disease
Phase 2CompletedAvid Radiopharmaceuticals792016-08-012020-08-24
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
18F-AV-1451 - Cognition Disorders
Phase 1CompletedUniversity of Southern California552016-08-012023-11-18
18F-AV-1451 PET Imaging in TBI
18F-AV-1451 - Traumatic Brain Injury
Phase 1WithdrawnAvid Radiopharmaceuticals2015-10-012016-02-05
18F-AV-1451 Autopsy Study
Flortaucipir F18, PET Scan - Alzheimer's Disease
Phase 3CompletedAvid Radiopharmaceuticals1562015-09-012020-09-07
Tau Imaging in Professional Fighters
Flortaucipir F18, Brain PET scan - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals352015-02-182020-09-10

Showing 20 of 67. Sign in to see all of them.

Conditions studied

Alzheimer Disease (48)  ·  Cognitive Dysfunction (11)  ·  Parkinson Disease (4)  ·  Brain Injuries, Traumatic (3)  ·  Neurodegenerative Diseases (3)  ·  Cognition Disorders (2)  ·  Dementia (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Frontotemporal Dementia (2)  ·  Lewy Body Disease (2)  ·  Amyloid Neuropathies, Familial (1)  ·  Brain Concussion (1)  ·  Cerebral Amyloid Angiopathy (1)  ·  Cerebral Hemorrhage (1)

Interventions

florbetapir (36)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (25)  ·  florbenazine F 18 (5)  ·  Magnetic Resonance Spectroscopy (4)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (3)  ·  gantenerumab (2)  ·  solanezumab (2)  ·  tau Proteins (2)  ·  (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole (1)  ·  Arginine (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Hematologic Tests (1)  ·  Magnetic Resonance Imaging (1)  ·  Physical Examination (1)  ·  flutemetamol (1)

Countries

United States (53)  ·  Australia (6)  ·  France (5)  ·  Japan (4)  ·  Canada (3)  ·  United Kingdom (3)  ·  Ireland (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Puerto Rico (2)  ·  Spain (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Germany (1)

Top investigators

Randall J Bateman, MD (2)  ·  Christoph Hock, Prof.Dr. med (1)  ·  David Irwin, MD (1)  ·  David O Okonkwo, MD, PhD (1)  ·  Douglas W Scharre, MD (1)  ·  Gary W Cline, Ph.D. (1)  ·  Kitt F Petersen, M.D. (1)

Results publications

PMID 22749065, PMID 33587110, PMID 42467182, PMID 20501908, PMID 21245183, PMID 24716655, PMID 28570698, PMID 29284675, PMID 30969506, PMID 31958082, PMID 32338734, PMID 32394598, PMID 32542468, PMID 33141172, PMID 36110925, PMID 37017737, PMID 38412412, PMID 38683602, PMID 39254220, PMID 39974075, PMID 40120616, PMID 40985290

NIH funding

R01AG046179 (2), U01AG042791 (2), R01AG053267 (1), R43NS063607 (1), R56AG053267 (1), U01AG059798 (1)